Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /524606
chevron_leftBack
Beryl Drugs Ltd. logo

Beryl Drugs Ltd.

524606
BSE: 524606 Delayed
21.95INR -4.6%
0.2301 USD
As of 7 June 2026, Beryl Drugs Ltd. has a market cap of $1.16M USD, ranking #48252 globally and #4935 in India. It ranks #4289 in the Healthcare sector, and #348 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
48252
Country Rank
4935
Sector Rank
4289
Industry Rank
348
Key Stats
Market Cap
$1.16MUSD
111.32M INR
Enterprise Value
$1.61MUSD
153.67M INR
Revenue (TTM)
$1.84MUSD
176.65M INR
EBITDA (TTM)
$150.66KUSD
14.37M INR
Net Income (TTM)
$1.47KUSD
141.0K INR
EBITDA Margin
8.1%
Profit Margin
0.1%
PE Ratio
789.5
PS Ratio
0.6
PB Ratio
1.2
EV/EBITDA
10.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sanjay Sethi open_in_new
Founded
1993
Website
beryldrugs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-4.6% -2.3% 25% 3.8% 6.2% 3.6%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
524606 (BERLDRG)
Beryl Drugs Ltd
ISIN: INE415H01017
Shares Out.:
5.072M1
TV:
SA:
YF:
GF:
BA:
MS:
21.95 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Beryl Drugs Ltd.

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
PE
CIPLA
$11.12B
1.06T INR
956K%
23.4
LUPIN
$11.0B
1.05T INR
946K%
22.7
AUROPHARMA
$8.43B
807.02B INR
725K%
23.1
SUVENPHAR
$1.87B
178.87B INR
161K%
199.0
GRANULES
$1.83B
174.85B INR
157K%
32.1
SEQUENT
$944.92M
90.48B INR
81K%
92.7
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
3M%
24.2
$29.56B
3M%
-
$15.86B
107.34B CNY
1M%
16.0
$9.1B
61.6B CNY
783K%
80.6
$8.79B
7.57B EUR
756K%
-
$5.22B
35.33B CNY
449K%
20.0
chevron_leftBack